PEDF is a promising candidate for ROP treatment as it is a natural antagonist of VEGF24 and a potent inhibitor of angiogenesis, as demonstrated in several animal models of ocular angiogenesis.23, 25, 26, 27, 28, 29. Here, SERPINF1 is linked to retinopathy of prematurity.